US Patent Issued to Hoffmann-La Roche on Sept. 8 for "Dosing for treatment with anti-CD20/anti-CD3 bispecific antibody" (Swiss, British, American, French, German Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,243, issued on Sept. 8, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Dosing for treatment with anti-CD20/anti-CD3 bispecific antibody" was invented by Linda Lundberg (Binningen, Switzerland), Peter N. Morcos (Marlboro, N.J.), Martin Weisser (Penzberg, Germany), Axel Boehnke (Muenchenstein, Switzerland), David Carlile (Princes Risborough, Great Britain) and Nassim Djebli (Rixheim, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating a B-cell proliferative disorder by administering an anti-CD20/anti-CD3 bispecific antibody, and methods for reduction of adverse effects in response t...